A detailed history of Jane Street Group, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Jane Street Group, LLC holds 5,954 shares of BDX stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,954
Previous 169,161 96.48%
Holding current value
$1.35 Million
Previous $39.5 Million 96.37%
% of portfolio
0.0%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $36.1 Million - $39.6 Million
-163,207 Reduced 96.48%
5,954 $1.44 Million
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $32.5 Million - $35.6 Million
144,589 Added 588.43%
169,161 $39.5 Million
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $17.5 Million - $18.6 Million
-75,148 Reduced 75.36%
24,572 $6.08 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $12.4 Million - $14.3 Million
53,554 Added 116.0%
99,720 $24.3 Million
Q3 2023

Nov 14, 2023

SELL
$254.9 - $283.59 $18.5 Million - $20.6 Million
-72,691 Reduced 61.16%
46,166 $11.9 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $24.3 Million - $27 Million
101,904 Added 601.1%
118,857 $31.4 Million
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $9.26 Million - $10.5 Million
-40,330 Reduced 70.4%
16,953 $4.2 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $4.95 Million - $5.83 Million
22,692 Added 65.6%
57,283 $14.6 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $1.02 Million - $5.28 Million
19,978 Added 136.71%
34,591 $7.71 Million
Q2 2022

Aug 16, 2022

SELL
$234.74 - $275.42 $41.5 Million - $48.7 Million
-176,659 Reduced 92.36%
14,613 $3.6 Million
Q1 2022

May 17, 2022

BUY
$243.64 - $270.48 $43.4 Million - $48.2 Million
178,040 Added 1345.53%
191,272 $50.9 Million
Q4 2021

Feb 15, 2022

SELL
$230.08 - $250.94 $2.42 Million - $2.64 Million
-10,511 Reduced 44.27%
13,232 $3.33 Million
Q3 2021

Nov 16, 2021

SELL
$232.72 - $256.47 $15.9 Million - $17.6 Million
-68,437 Reduced 74.24%
23,743 $5.84 Million
Q2 2021

Aug 16, 2021

BUY
$232.65 - $254.58 $8.41 Million - $9.21 Million
36,165 Added 64.56%
92,180 $22.4 Million
Q1 2021

May 18, 2021

BUY
$232.09 - $256.88 $3.55 Million - $3.93 Million
15,281 Added 37.51%
56,015 $13.6 Million
Q4 2020

Feb 17, 2021

SELL
$221.92 - $245.94 $4.52 Million - $5.01 Million
-20,363 Reduced 33.33%
40,734 $10.2 Million
Q3 2020

Nov 17, 2020

BUY
$215.77 - $276.76 $12.2 Million - $15.6 Million
56,413 Added 1204.38%
61,097 $14.2 Million
Q2 2020

Aug 17, 2020

SELL
$219.9 - $263.41 $2.99 Million - $3.59 Million
-13,617 Reduced 74.41%
4,684 $1.12 Million
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $752,036 - $1.07 Million
-3,843 Reduced 17.35%
18,301 $4.21 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $5.83 Million - $6.47 Million
-25,272 Reduced 53.3%
22,144 $5.6 Million
Q2 2019

Aug 15, 2019

BUY
$217.4 - $246.08 $6.79 Million - $7.69 Million
31,248 Added 193.27%
47,416 $11.9 Million
Q1 2019

May 16, 2019

BUY
$206.05 - $248.17 $80,359 - $96,786
390 Added 2.47%
16,168 $4.04 Million
Q4 2018

Feb 15, 2019

BUY
$204.73 - $257.93 $3.04 Million - $3.83 Million
14,834 Added 1571.4%
15,778 $3.56 Million
Q3 2018

Nov 14, 2018

SELL
$233.07 - $256.0 $7.89 Million - $8.67 Million
-33,860 Reduced 97.29%
944 $246,000
Q2 2018

Aug 15, 2018

BUY
$208.1 - $233.85 $5.59 Million - $6.28 Million
26,844 Added 337.24%
34,804 $8.34 Million
Q1 2018

May 15, 2018

SELL
$205.46 - $240.27 $2.62 Million - $3.07 Million
-12,768 Reduced 61.6%
7,960 $1.73 Million
Q4 2017

Feb 15, 2018

BUY
$189.0 - $222.64 $3.5 Million - $4.12 Million
18,502 Added 831.18%
20,728 $4.44 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $416,017 - $442,751
2,226
2,226 $436,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.